Loading...

Intraperitoneal ziv-aflibercept effectively manages refractory ascites in colorectal cancer patients

Ascites related to metastatic colorectal cancer (mCRC) reduces patient survival and quality of life, and systemic chemotherapy is largely ineffective for managing ascites. Here, we examined the clinical efficacy of intraperitoneal (IP) ziv-aflibercept for managing refractory ascites in 15 mCRC patie...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncotarget
Main Authors: Lu, Chieh-Sheng, Lin, Jen-Kou, Chen, Wei-Shone, Lin, Tzu-Chen, Jiang, Jeng-Kai, Yang, Shung-Haur, Wang, Huann-Sheng, Chang, Shih-Ching, Lan, Yuan-Tzu, Lin, Chun-Chi, Lin, Hung-Hsin, Teng, Hao-Wei
Format: Artigo
Sprog:Inglês
Udgivet: Impact Journals LLC 2016
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5482690/
https://ncbi.nlm.nih.gov/pubmed/27888621
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13543
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!